← Back to Search

Transplant Wellness Clinic for Stem Cell Transplant Complications

N/A
Recruiting
Led By Linda M Baer, APRN
Research Sponsored by Case Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Outpatient at time of enrollment.
Stem cell transplant candidates > 60 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 100 days after transplant
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new clinic that could help older stem cell transplant patients manage their side effects and other medical conditions.

Who is the study for?
This trial is for stem cell transplant candidates aged over 60 or younger patients with significant health complexities. Participants must be outpatients, able to attend appointments, read and understand English for questionnaires, and have a window of 4-12 weeks before their transplant starts. It's not open to those deemed unsuitable for transplantation.
What is being tested?
The study aims to create a clinic that assesses the needs of older or high-risk patients undergoing bone marrow transplants (BMT). It includes comprehensive evaluations like physical therapy consults, nutrition assessments, cognitive tests, medication reviews and follow-ups to potentially improve outcomes and reduce hospital stays.
What are the potential side effects?
Since this trial focuses on pre-transplant care rather than medications or treatments directly administered during BMT procedures, it does not list specific side effects related to drugs but may identify areas needing intervention such as physical fitness or nutritional status.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am not hospitalized and can visit the clinic for treatments.
Select...
I am over 60 years old and a candidate for a stem cell transplant.
Select...
I am 4 to 12 weeks away from starting my transplant procedures.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 100 days after transplant
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 100 days after transplant for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Length of transplant stay in days
Patient satisfaction as determined by "patient follow-up quesitonnaire"
Physician satisfaction as determined by "physician questionnaire"
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Transplant Wellness ClinicExperimental Treatment9 Interventions
* Physical therapy consult * Intake vitals * CARG online survey, mental status exam * Medication review * Nutrition survey * Social work: available on prn basis (as-needed) * Exit survey Recommendations made and given to the participant and sent to the referring MD. Participant receives post clinic phone call before transplant. Referring MD receives questionnaires. Data collected depending on if participant moved forward with transplant

Find a Location

Who is running the clinical trial?

Case Comprehensive Cancer CenterLead Sponsor
468 Previous Clinical Trials
33,416 Total Patients Enrolled
Linda M Baer, APRNPrincipal InvestigatorUniversity Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Kirsten M Boughan, DOPrincipal InvestigatorUniversity Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center

Media Library

Cancer Aging Research Group (CARG) assessment Clinical Trial Eligibility Overview. Trial Name: NCT04194840 — N/A
Stem Cell Transplant Complications Research Study Groups: Transplant Wellness Clinic
Stem Cell Transplant Complications Clinical Trial 2023: Cancer Aging Research Group (CARG) assessment Highlights & Side Effects. Trial Name: NCT04194840 — N/A
Cancer Aging Research Group (CARG) assessment 2023 Treatment Timeline for Medical Study. Trial Name: NCT04194840 — N/A
~0 spots leftby Dec 2024